We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
For some time now, GlaxoSmithKline in London, UK, has fallen behind its peers and its head of pharmaceuticals, Luke Mills, is pushing his department to work to cut the budget by 20%.